We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » British Drugmaker Facing New Bribery Allegations From Polish Regulator
British Drugmaker Facing New Bribery Allegations From Polish Regulator
GlaxoSmithKline says it is under investigation in Poland for allegedly bribing doctors to promote the asthma drug Seretide (fluticasone propionate/salmeterol xinafoate).
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor